Ceragenix Pharmaceuticals - Ceragenix loses almost $13M in 2005
Ceragenix loses almost $13M in 2005
Denver Business Journal - The Denver company (OTCBB: CGXP), which doesn't have any revenue yet, has lost $13.8 million since 2002. During 2004, the company posted a net loss of $825,711. The red ink amounted to a loss of $1.06 per share last year, up from a loss of 7 cents
Latest News
dBusinessNews.com - Denver: Avian Influenza Pandemic Operational Continuity Training Now Available Online From NexPort Solutions and NEHA DENVER -- NexPort Solutions and the National Environmental Health Association Denver: Ceragenix Pharmaceuticals to Present at